Metabolic syndrome and intestinal microbiota in children
DOI:
https://doi.org/10.52556/2587-3873.2024.5(102).05Keywords:
microbiota, metabolic syndrome, obesity, childrenAbstract
The prevalence of metabolic syndrome is constantly increasing among pediatric subjects, and the most recent studies suggest that there is a possible relationship between the gut microbiome and this syndrome. The bibliographic analysis of the scientific literature regarding the correlation between the metabolic syndrome in children and the intestinal microbiota published in the last 5 years was carried out, using the search portals Sciencedirect, Pubmed, Library Genesis, Medscape. Changes in the process of human intestinal microbial maturation begin at the moment of conception, and the main predisposing factors are: the mother’s diet, her obesity, vaginal or cesarean delivery, the type of infant nutrition, the drugs used. The 2 most important families in the gastrointestinal tract are Firmicutes and Bacteroidetes, which represent 90% of the intestinal microbiota, responsible, through their ability to produce certain chemicals, with the potential to disrupt metabolic activities: childhood obesity, insulin resistance, abnormal metabolism of glucose, elevated BP, dyslipidemia, inflammation, and compromised vascular function. The gut microbiota in children has been shown to be more flexible to changes derived from maternal and acquired factors. The key bacteria in the development of obesity in children are part of the Firmicutes and Bacteroidetes families, while Bifidobacterium and the abundance of Lactobacillus paracasei was negatively correlated with obesity. The association between high blood pressure and diabetes with the intestinal microbiota has also been demonstrated, which represents another side of the metabolic syndrome. Targeted microbiota modifications: drug treatment, modulation with probiotics and diet are useful in conducting this pathology in children.
References
1. CARRIZALES-SÁNCHEZ, A.K., et al. Gut microbiota associations with metabolic syndrome and relevance of its study in pediatric subjects. In: Gut Microbe 2021, nr. 7. https://doi.org/10.1080/19490976.2021.1960135
2. LAKSHMANAN, A.P., et al. Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus. In: Biomedicine & Pharmacotherapy. 2021, nr. 140, 111736. https://doi.org/10.1016/j.biopha.2021.111736
3. BACORN, M., et al. In: The Gut Microbiome of Children during the COVID-19 Pandemic. In: Microorganisms. 2022, nr. 10(12):2460.
https://doi.org/10.3390/microorganisms10122460
4. BECKY MCCALL, Gut bacteria in toddlers predictive of later weight gain. In: Conference News ECO 2023, medscape, 2023.
5. BEŁTOWSKI, J., WÓJCICKA, G., JAMROZ-WIŚNIEWSKA, A. Hydrogen sulfide in the regulation of insulin secretion and insulin sensitivity: implications for the pathogenesis and treatment of diabetes mellitus. In: Biochem Pharmacol. 2018, nr. 149, pp. 60-76. https://doi.org/10.1016/j.bcp.2018.01.004
6. JIAN, C., CARPÉN. N., HELVE, O., et al. Early-life gut microbiota and its connection to metabolic health in children: Perspective on ecological drivers and need for quantitative approach, In: EBioMedicine. 2021, nr. 69, 103475. https://doi.org/10.1016/j.ebiom.2021.103475
7. AL-HAMAD, D., VANDANA R. Metabolic syndrome in children and adolescents. In: Transl Pediatr. 2017 nr. 6(4): pp. 397-407. doi: 10.21037/tp.2017.10.02 https://doi.org/10.21037/tp.2017.10.02
8. DERRIEN, M., ALVAREZ, A.S., DE VOS, W.M. The Gut Microbiota in the First Decade of Life. In: Trends Microbiology 2019, nr. 27(12), pp. 997-1010. https://doi.org/10.1016/j.tim.2019.08.001
9. FERRETTI, P., PASOLLI, E., TETT, A. Mother-to-Infant Microbial Transmission from Different Body Sites Shapes the Developing Infant Gut Microbiome. In: Cell Host Microbe 2018;24(1):133-45 e5. https://doi.org/10.1016/j.chom.2018.06.005
10. GAO, R., ZHU, C., LI, H., et al. Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity. Obesity (Silver Spring) 2018, nr. 26, pp. 351-61. https://doi.org/10.1002/oby.22088
11. GARCÍA-MANTRANA, I., SELMA-ROYO, M., GONZALEZ, S., Distinct maternal microbiota clusters are associated with diet during pregnancy: impact on neonatal microbiota and infant growth during the first 18 months of life. In: Gut Microbes. 2020, nr.11(4), pp. 962-78. https://doi.org/10.1080/19490976.2020.1730294
12. KORPELA, K., RENKO, M., VANNI, P. Microbiome of the € first stool and overweight at age 3 years: A prospective cohort study. In: Pediatric Obesity 2020, nr. 15(11):e12680. https://doi.org/10.1111/ijpo.12680
13. KORPELA, K., SALONEN, A., SAXEN, H. Antibiotics in early life associate with specific gut microbiota signatures in a prospective longitudinal infant cohort. In: Pediatr Res 2020, nr. 88(3), pp. 438-43. https://doi.org/10.1038/s41390-020-0761-5
14. KIMURA, I., MIYAMOTO, J., OHUE-KITANO, R. Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice. In: Science 2020, nr. 367, 6481 eaaw8429. https://doi.org/10.1126/science.aaw8429
15. KY Y.OUNG CHO. Association of gut microbiota with obesity in children and adolescents. In: Clinical and experimental pediatrics. 2023, nr. 66(4), pp. 148-154. https://doi.org/10.3345/cep.2021.01837
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
